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background:  Recurrences of atrial fibrillation (AF) occur in up to 50 % within one year after catheter ablation but their prediction remains 
challenging. Several studies have demonstrated a moderate performance of the CHADS2 and CHA2DS2-VASc scores for prediction of rhythm 
outcomes, few other, partly complex, risk scores have been developed but not validated. Therefore, the purpose of this study was to (1) assess a 
simple score for the prediction of rhythm outcome of AF catheter ablation, (2) compare it with the CHADS2 and CHA2DS2-VASc scores, and (3) 
validate it in an external AF ablation cohort.
methods:  1,410 patients (60 ± 10 years, 66% male, 65% paroxysmal AF) undergoing their first AF catheter ablation were included. Using serial 
ECG and 7-day Holter ECG monitoring between 3 and 12 months after ablation, AF recurrences > 30 sec were observed in 472 patients (34%). Based 
on uni- and multivariate analysis results, AF recurrences were predicted using the APPLE score (one point for Age >65 years, Persistent AF, imPaired 
eGFR (<60 ml/min/1.73m2), Left atrial diameter ≥43 mm, Ejection fraction <50%).
results:  While the CHADS2 (AUC 0.546, 95% CI 0.514-0.578, p=0.005) and CHA2DS2-VASc (AUC 0.551, 95% CI 0.518-0.583, p=0.002) scores 
demonstrated low predictive value, the APPLE score ranging from 0 to 5 points, showed better prediction of AF recurrences (AUC 0.630, 95% CI 
0.599-0.660, p<0.001). Patients with APPLE score of 0 (22%), 1 (35%), 2 (29%), and ≥3 (14%) had AF recurrence rates of 19%, 31%, 39%, and 53%, 
respectively (p<0.001). Compared to patients with an APPLE score of 0, the risk (OR) for AF recurrences was 1.9 (95% CI 1.4-2.7), 2.8 (95% CI 2.0-
4.0) and 4.9 (95% CI 3.3-7.3) for APPLE scores 1, 2, or ≥3, respectively (all p<0.001). In an external validation cohort of 311 AF patients (58 ± 11 
years, 72% male, 49% paroxysmal AF) with comparable ablation and follow-up, the APPLE score showed similar results (AUC 0.624, 95% CI 0.562-
0.687, p<0.001).
conclusions:  The novel and simple APPLE score is superior to the CHADS2 and CHA2DS2-VASc scores for prediction of rhythm outcomes after 
catheter ablation. It may be a suitable prognosticator to identify patients with low, intermediate or high risk for AF recurrences.
